Industry

AIBN was established with the specific aim of combining research excellence with an industry focus.

The commercial objectives of the Institute are to:

Produce innovations assisting in the growth of industries;
Develop new products, processes and technologies; and
To play a major role in developing the Australian nanotechnology and biotechnology industries, through establishing new opportunities, obtaining the support of the industry sector and interfacing with industrial collaborators.

AIBN has worked to develop and promote:

A culture of commercialisation within the Institute;
Strategies to support the Institute’s commercialisation and industry engagement;
The Institute’s R&D capabilities and infrastructure to industry; and
A suite of quality patent assets relevant to industry and market need.

Continuing Professional Development

Industrial relevance

How we work with industry

Professor Justin Cooper-White with Scaled Biolabs co-founders Drew Titmarsh (right) and Brendan Griffen (left)

Start-up makes quick work of cellular experiments

6 February 2017

Start-up company Scaled Biolabs Inc is changing the way researchers around the world conduct manual cellular experiments and accelerating discoveries in biology by providing novel devices that enable 1000’s of experiments to occur simultaneously.

UQ-Amyris collaboration seeks to accelerate development of Queensland ‘Biofutures Hub’

7 June 2016

Leading American biotechnology company Amyris, Inc. and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland have signed a Memorandum of Understanding to support the development of a Queensland-based biotechnology industry using feedstock from local sugarcane.

New $4.5 million facility opens doors to stronger collaboration

16 January 2014

A new facility for enzyme formulation and production has been opened, strengthening a collaboration between the Australian Institute for Bioengineering and Nanotechnology and industry partner Bioproton.